Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLG1218 (daprodustat tablets) for renal anemia in hemodialysis
CTR20254434Phase 3Active
- Sponsor
- Qilu Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daprodustat in anemia of renal disease, sponsored by Qilu Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
daprodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on CTR20254434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254434.